Summary
SMLR Chart
Semler Scientific, Inc. (SMLR) Q1 2025 Earnings Call Transcript
Semler Scientific, Inc. (NASDAQ:SMLR ) Q1 2025 Earnings Conference Call May 13, 2025 4:00 PM ET Company Participants Doug Murphy-Chutorian - CEO Eric Semler - Chairman Jennifer Oliva Herrington - COO Renae Cormier - CFO Operator Good afternoon and welcome to the Semler Scientific First Quarter 2025 Financial Results Conference Call. All participants will be in a listen-only mode.
Semler Scientific: Options And Bitcoin Will Make This A Billion Dollar Company
Semler Scientific's Bitcoin treasury strategy has significantly boosted its stock price, rising from under $30 to over $70 per share. The company's BTC Yield metrics are impressive, with a 67% QTD yield and 92.8% since adopting the Bitcoin strategy, driving superior shareholder performance (as of 16 Dec 2024). The introduction of an options market for SMLR is a major bullish development, potentially enabling convertible bond issuances to further increase BTC per share.
Semler Scientific: Booking Some Profits After Bitcoin Strategy
Semler Scientific's stock has surged 100% due to its Bitcoin strategy, adding diversification and potential capital appreciation, despite inherent crypto volatility. SMLR's Bitcoin holdings, valued at $147M, enhance its market cap and balance sheet, offering a hedge against inflation and attracting new investors. Risks include Bitcoin's price volatility and regulatory uncertainties, which could decouple the Company's stock price from its core business fundamentals.
Semler Scientific Inc. (SMLR) FAQ
What is the stock price today?
On which exchange is it traded?
What is its stock symbol?
Does it pay dividends? What is the current yield?
What is its market cap?
When is the next earnings date?
Has Semler Scientific Inc. ever had a stock split?
Semler Scientific Inc. Profile
| Medical - Devices Industry | Healthcare Sector | Douglas Murphy-Chutorian CEO | NASDAQ (CM) Exchange | 81684M104 Cusip |
| US Country | 79 Employees | - Last Dividend | - Last Split | 21 Feb 2014 IPO Date |
Overview
Semler Scientific, Inc., based in Santa Clara, California, is a technology company focused on providing advanced solutions to enhance the clinical operations and effectiveness of healthcare providers across the United States. Incorporated in 2007, Semler Scientific lays emphasis on innovating and distributing products that aid in the assessment and management of vascular conditions and diabetes care. Their client base encompasses a wide range of healthcare professionals and organizations, including cardiologists, internists, nephrologists, endocrinologists, podiatrists, and family practitioners, as well as healthcare insurance plans, integrated delivery networks, independent physician groups, and companies in the healthcare industry such as risk assessment groups and retailers. Distribution is achieved through a combination of direct sales representatives and distributors, ensuring their cutting-edge products are accessible to a broad spectrum of healthcare providers.
Products and Services
-
QuantaFlo:
This product stands out as a quick and efficient in-office test designed to measure blood flow, taking only about four minutes to complete. QuantaFlo's technology enables healthcare providers to easily incorporate blood flow measurements into their examination process, aiding in the assessment of a patient's vascular health. This tool is particularly useful for professionals aiming to diagnose and manage vascular conditions with greater accuracy and speed.
-
Insulin Insights:
A sophisticated software program, Insulin Insights is crafted to assist healthcare providers in optimizing insulin dosing for outpatients. By utilizing this tool, medical practitioners can achieve more precise and individualized insulin dose recommendations, enhancing the overall management of diabetes. This program underscores Semler Scientific's commitment to supporting healthcare providers in delivering better diabetes care, by leveraging advanced technology to improve treatment outcomes for patients.
Contact Information
